Document is current
Any future updates will be listed below
-
Authors
Pulica, Rachael
Aquib, Ahmed
Varsanyi, Christopher
Gadiyar, Varsha
Wang, Ziren
Frederick, Trevor
Calianese, David C.
Patel, Bhumik
de Dios, Kenneth Vergel
Poalasin, Victor
De Lorenzo, Mariana S.
Kotenko, Sergei V.
Wu, Yi
Yang, Aizen
Choudhary, Alok
Sriram, Ganapathy
Birge, Raymond B.
-
Funding
Funding for this research was provided by:
National Cancer Institute (1R01CA260137-01A1, 1R01CA260137-01A1)
- License Information
-
More Information
Article History
Received: 21 November 2024
Accepted: 7 February 2025
First Online: 11 March 2025
Declarations
:
: SVK and RBB are co-founders of a biotech company called Targeron Therapeutics that aim to develop PS-targeting biologicals. Other authors have nothing to declare.
